HARVARD BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $3.30 per share for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2019-11-08
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2019-03-31 was $3.26, a 8.67% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2018-03-31 was $3.00, a 8.54% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for the quarter ending 2017-03-31 was $3.28.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2018 was $2.88, a 6.49% decline from fiscal 2017.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2017 was $3.08.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2019-09-30 | $3.30 10-Q · filed 2019-11-08 | |||
| 2019-06-30 | $3.46 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | $3.26 10-Q · filed 2019-05-08 | |||
| 2018-12-31 | $2.88 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $2.87 10-Q · filed 2018-11-01 | |||
| 2018-06-30 | $2.86 10-Q · filed 2018-08-02 | |||
| 2018-03-31 | $3.00 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | $3.08 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $3.09 10-Q · filed 2017-11-02 | |||
| 2017-06-30 | $3.28 10-Q · filed 2017-08-03 | |||
| 2017-03-31 | $3.28 10-Q · filed 2017-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |